Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

Johnson & Johnson Covid vaccine

Aspen Pharmacare is planning to increase its manufacturing capacity for Johnson & Johnson's Covid-19 vaccine in South Africa by 200 million.

| Justin Tallis | AFP

Kenya to receive batch of J&J vaccine

Kenya is among 17 African countries that will receive 6.4 million doses of Johnson & Johnson Covid-19 vaccines this month.

This follows the World Bank’s approval of $2 billion in financing to the African Vaccine Acquisition Task Team (Avatt) initiative that has secured up to 400 million doses of the vaccine.